Valspar

Valspar Corporation (The)

NYSE

Valaris Ltd is the industry leader in offshore drilling services across all water depths and geographies. It is a high-quality rig fleet of ultra-deepwater drillships, versatile semisubmersibles and modern shallow-water jackups.

Valaris

Valaris Limited Warrants

VALE S.A. American Depositary Shares Each Representing one common share

Vale

Valneva

Valaris Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAL#NYSE">VAL</a>) announced today that it has been awarded a three-year contract with Chevron in the U.S. Gulf of Mexico for drillship, VALARIS DS-18 (Relentless). The contract is expected to commence in the first quarter of 2022 in direct continuation of the current contract.

News

Contracts

Valaris Announces Floater Contract Award; Size Not Disclosed

Valaris Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAL#NYSE">VAL</a>) announced today that it has been awarded a two-well contract extension with Equinor Energy AS offshore Norway for VALARIS JU-291 (Stavanger), a heavy-duty ultra-harsh environment jackup. The extension is for an estimated 120 days in direct continuation of the existing contract and, as a result, the VALARIS JU-291 is now expected to be under contract through February 2022.

Valaris Limited Announces Co. Has Been awarded A Two-Well Contract Extension With Equinor Energy AS Offshore Norway For VALARIS JU-291

alaris Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAL#NYSE">VAL</a>) announced today that it has been awarded a one-well contract with Total E&amp;P C&ocirc;te d&#39;Ivoire B.V. offshore&nbsp;Ivory Coast&nbsp;for drillship, VALARIS DS-12. The contract is expected to commence in the&nbsp;third quarter&nbsp;of 2021.

Valaris Says Awarded 1-Well Contract With Total E&P  Côte d'Ivoire B.V. Offshore Ivory Coast For Drillship, VALARIS DS-12; Says Contract Expected To Commence Q3 2021

Valaris Wins 45-Day Contract With W&T Offshore In Gulf Of Mexico For VALRIS JU-117 (Ralph Coffman) Jackup, No Terms Disclosed

LONDON,&nbsp;Aug. 25, 2020&nbsp;/PRNewswire/ --Valaris plc (NYSE:<a class="ticker" href="/stock/VAL#NYSE">VAL</a>) (&quot;Valaris&quot; or the &quot;Company&quot;) announced today that on&nbsp;August 19, 2020&nbsp;it was notified by the New York Stock Exchange (&quot;NYSE&quot;) of its determination to indefinitely suspend trading of the Company&#39;s common stock and to commence proceedings to delist the Company&#39;s common stock from the NYSE. This suspension and delisting by the NYSE is in accordance with Section 802.01D of the NYSE Listed Company Manual due to the Company&#39;s voluntary filing for reorganization under Chapter 11 of the Bankruptcy Code on&nbsp;August 19, 2020.

Valaris plc Receives NYSE Notice of Immediate Suspension of Trading and Delisting of Valaris Common Stock

Valaris Shares Suspended Trading on NYSE

LONDON,&nbsp;Aug. 19, 2020&nbsp;/PRNewswire/ -- Valaris plc (NYSE:<a class="ticker" href="/stock/VAL#NYSE">VAL</a>) (&quot;Valaris&quot; or the &quot;Company&quot;) today announced that it has entered into a binding Restructuring Support Agreement (the &quot;RSA&quot;) and Backstop Commitment Agreement (the &quot;BCA&quot;) with approximately&nbsp;50%&nbsp;of its noteholders (&quot;Consenting Noteholders&quot;). Valaris will undergo a financial restructuring that is intended to reduce its debt load substantially, support continued operations during the current lower demand environment and provide a robust financial platform to take advantage of market recovery over the long term.
The RSA and the BCA contemplate, among other items, the full equitization of the Company&#39;s pre-petition revolving credit facility and unsecured notes, a fully backstopped rights offering to noteholders for&nbsp;$500 million&nbsp;of new secured notes, the effective cancellation of existing equity interests in the Company in exchange for, in certain circumstances, warrants for post-emergence equity and payment of trade claims in full in cash.
To implement the terms of the RSA and the BCA, Valaris voluntarily filed for a Chapter 11 financial restructuring (the &quot;Chapter 11 Cases&quot;) in&nbsp;the United States&nbsp;Bankruptcy Court for the Southern District of&nbsp;Texas&nbsp;(the &quot;Bankruptcy Court&quot;).
Valaris aims to pursue an efficient restructuring process and exit Chapter 11 as soon as possible and is confident that a comprehensive financial restructuring is in the best interest of the Company and its stakeholders in the long-term. Upon consummation of the contemplated restructuring transactions, Valaris will have one of the best balance sheets in the offshore drilling industry.
The Company remains confident that it will be able to maintain liquidity and operate in the ordinary course of business as a result of having approximately&nbsp;$175 million&nbsp;in cash and committed Debtor-in-Possession (&quot;DIP&quot;) financing from certain of its noteholders to provide the Company with an additional&nbsp;$500 million&nbsp;of liquidity, with an option to have no cash interest, to support its operations throughout the Chapter 11 process.
&quot;The substantial downturn in the energy sector, exacerbated by the COVID-19 pandemic, requires that we take this step to create a stronger company able to adapt to the prolonged contraction in the industry, and to continue to enhance our position as overall market conditions improve,&quot; said&nbsp;Tom Burke, President and Chief Executive Officer of Valaris.
Burke continued: &quot;We have taken several steps to right-size and streamline our organization in line with our goal to be the offshore drilling cost leader. Now, we intend to use this restructuring to complement these measures to create a stronger financial structure for the Company. Valaris will continue to serve our customers uninterrupted through this process, delivering safe and reliable operations, through its highly-capable rig fleet.&quot;
Burke concluded: &quot;We appreciate the continued support of all of our stakeholders throughout this process, particularly our employees who continue to provide excellent service to our customers amid challenging market conditions, while upholding the Valaris values of integrity, safety, excellence, respect, ingenuity, and stewardship.&quot;
The Company looks forward to working with its other creditors and stakeholders who have not signed the RSA to advance the Company&#39;s efforts to restructure its balance sheet.
Kirkland &amp; Ellis LLP and Slaughter and May are serving as legal advisors to Valaris in connection with the restructuring. Lazard Ltd. is serving as Valaris&#39; investment banker and Alvarez &amp; Marsal North America LLC as its restructuring advisor.&nbsp;Kramer Levin Naftalis&nbsp;&amp; Frankel LLP and Akin Gump Strauss Hauer &amp; Feld LLP are serving as legal advisors to the Consenting Noteholders, and Houlihan Lokey Inc. is serving as financial advisor.
Court filings and other information related to the Court-supervised proceedings are available at a website administered by the Company&#39;s claims agent, Stretto,&nbsp;<a href="http://cases.stretto.com/Valaris">http://cases.stretto.com/Valaris</a>. Questions should be directed to our dedicated restructuring hotline 855-348-2032 (Toll-Free) or +1 949-266-6309 (International).

Valaris Announces Binding Restructuring Support Agreement And Backstop Commitment Agreement With Approximately 50% Of Its Noteholders

<h3>Gainers</h3>
<ul>
<li>Stein Mart, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smrt#NASDAQ">SMRT</a>) shares rose 93.8% to $0.2120 in pre-market trading after dropping 11% on Friday. Stein Mart, last week, filed for Chapter 11 bankruptcy.</li>
<li>CureVac N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvac#NASDAQ">CVAC</a>) rose 65.4% to $92.48 in pre-market trading. CureVac shares jumped 249% on Friday after pricing its IPO at $16 per share.</li>
<li>LMP Automotive Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lmpx#NASDAQ">LMPX</a>) shares rose 56.6% to $10.90 in pre-market trading following Q2 results. The company&rsquo;s earnings came in at $0.02 per share, while revenue jumped 44% to $7.716 million.</li>
<li>Cellectar Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clrb#NASDAQ">CLRB</a>) rose 30.8% to $1.87 in pre-market trading after gaining around 6% on Friday. Cellector Biosciences, last week, filed for a mixed shelf offering of up to $100 million.</li>
<li>Valaris plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/val#NYSE">VAL</a>) rose 24.2% to $0.41 in pre-market trading after dropping 12% on Friday. CoreCivic will replace Valaris in the S&amp;P SmallCap 600 from today.</li>
<li>Sonoma Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snoa#NASDAQ">SNOA</a>) rose 22.6% to $9.27 in pre-market trading following Q1 results. Sonoma Pharmaceuticals reported Q1 earnings of $0.02 per share on sales of $7.30 million.</li>
<li>Town Sports International Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/club#NASDAQ">CLUB</a>) rose 21% to $0.84 in pre-market trading after jumping over 48% on Friday as New York Governor Cuomo made remarks on gyms reopening.</li>
<li>Datasea Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dtss#NASDAQ">DTSS</a>) rose 19.4% to $3.38 in pre-market trading. Datasea, last week, received second subsidy from the Harbin Municipal Government to develop its Safe Campus Management System.</li>
<li>Waitr Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wtrh#NASDAQ">WTRH</a>) rose 16.8% to $4.88 in pre-market trading. Waitr Holdings, earlier during the month, released Q2 results.</li>
<li>9 Meters Biopharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtr#NASDAQ">NMTR</a>) rose 14% to $0.6484 in pre-market trading after jumping 20% on Friday. 9 Meters Biopharma reported Q2 results last week.</li>
<li>Lithium Americas Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lac#NYSE">LAC</a>) shares rose 14% to $9.00 in pre-market tradin. Lithium Americas shares gained around 8% on Friday after releasing Q2 results.</li>
<li>Jaguar Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jagx#NASDAQ">JAGX</a>) rose 13.3% to $0.57 in pre-market trading after declining 9% on Friday. Jaguar Health, last week, reported downbeat Q2 results.</li>
<li>Applied DNA Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apdn#NASDAQ">APDN</a>) rose 12.8% to $10.48 in pre-market trading. Applied DNA Sciences has filed a non provisional patent application with the United States Patent and Trademark Office entitled &quot;Methods and Systems of PCR-Based Recombinant Adeno-Associated Virus Manufacture.&quot;</li>
<li>Future FinTech Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ftft#NASDAQ">FTFT</a>) rose 12.7% to $2.85 in pre-market trading after the company announced plans to enter the challenger bank and digital payment sector.</li>
<li>CooTek (Cayman) Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ctk#NYSE">CTK</a>) rose 11.3% to $7.45 in pre-market trading. CooTek is expected to release Q2 earnings on August 18.</li>
<li>Zion Oil &amp; Gas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zn#NASDAQ">ZN</a>) rose 10.7% to $0.4299 in pre-market trading after falling more than 9% on Friday.</li>
<li>Puhui Wealth Investment Management Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/phcf#NASDAQ">PHCF</a>) rose 10.5% to $4.00 in pre-market trading after climbing 13% on Friday.</li>
<li>TORM plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trmd#NASDAQ">TRMD</a>) shares rose 10.2% to $8.55 in pre-market trading after the company reported Q2 earnings results.</li>
<li>DPW Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dpw#NYSE">DPW</a>) rose 9.4% to $2.32 after reporting preliminary results for the second quarter.</li>
<li>Tricida, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcda#NASDAQ">TCDA</a>) rose 9.3% to $15.50 in pre-market trading. Tricida announced Q2 results earlier during the month.</li>
<li>Principia Biopharma Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prnb#NASDAQ">PRNB</a>) shares rose 9.2% to $99.05 in pre-market trading after Sanofi announced plans to purchase the company for $3.7 billion.</li>
<li>Barrick Gold Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gold#NYSE">GOLD</a>) shares rose 9% to $29.40 in pre-market trading. According to a SEC filing, Warren Buffett&#39;s Berkshire Hathaway purchased 20.9 million shares in Barrick Gold.</li>
<li>Sundial Growers Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) rose 8.1% to $0.4859 in pre-market trading. Sundial Growers shares tumbled 36% on Friday after the company reported a 25.82 million unit offering at $0.50 per unit.</li>
<li>Pluristem Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/psti#NASDAQ">PSTI</a>) shares rose 7.7% to $9.39 in pre-market trading. Pluristem and Abu Dhabi Stem Cells Center signed a MOU to collaborate in the development of cell therapies and regenerative medicines for the treatment of severe diseases including COVID-19.</li>
<li>G1 Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gthx#NASDAQ">GTHX</a>) rose 7.3% to $17.00 after the company announced the FDA has accepted its new drug application and has granted priority review for Trilaciclib with small cell lung cancer.&nbsp;</li>
<li>Kitov Pharma Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktov#NASDAQ">KTOV</a>) rose 7% to $0.5640 in pre-market trading after declining over 10% on Friday. Kitov Pharma released H1 results last week.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) shares rose 5.8% to $0.80 in pre-market trading. VistaGen Therapeutics shares fell 7% on Friday after reporting a Q1 loss of $0.07 per share.</li>
<li>UP Fintech Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tigr#NASDAQ">TIGR</a>) rose 5.8% to $6.90 in pre-market trading. UP Fintech is projected to release Q2 results on August 18.</li>
<li>Suncor Energy Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/su#NYSE">SU</a>) rose 5.8% to $18.00 in pre-market trading after Warren Buffett&#39;s Berkshire Hathaway issued a 13-F filing on Friday indicating the firm has raised its stake in Suncor Energy by 28.4% to 19.2 million shares.</li>
<li>Cinemark Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cnk#NYSE">CNK</a>) rose 5.5% to $13.38 in pre-market trading Cinemark shares gained over 7% on Friday after the company announced it would reopen its US theaters beginning on August 14th.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Midatech Pharma plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtp#NASDAQ">MTP</a>) fell 19.1% to $2.20 in pre-market trading. Midatech Pharma shares jumped 45% on Friday after the company reported that registration statement has been declared effective by the SEC relating to the permitted resale of up to 12,695,445 ordinary shares.</li>
<li>Interpace Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/idxg#NASDAQ">IDXG</a>) fell 16% to $4.86 in pre-market trading after declining over 4% on Friday.</li>
<li>Taiwan Liposome Company, Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlc#NASDAQ">TLC</a>) shares fell 15.9% to $5.99 in pre-market trading. Taiwan Liposome shares gained 40% on Friday following press release highlighting submission of investigational new drug application for TLC19 inhalable liposomal hydroxychloroquine for coronavirus infection.</li>
<li>Medley Management Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdly#NASDAQ">MDLY</a>) fell 15.4% to $0.6004 in pre-market trading after the company swung to a loss in the second quarter while revenue declined to $8.6 million from $12.9 million.</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) fell 11.8% to $0.4542 in pre-market trading. Senmiao Technology, earlier during the month, announced a 12 million share common stock offering at $0.50 per share.</li>
<li>Farmmi, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fami#NASDAQ">FAMI</a>) fell 10.5% to $0.9575 in pre-market trading. Farmmi shares jumped over 40% on Friday after the company reported that its Zhejiang Forest Food Co. received new customer orders for dried whole mushrooms and slices.</li>
<li>ThermoGenesis Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thmo#NASDAQ">THMO</a>) fell 10.2% to $4.25 in pre-market trading. Thermogenesis reported a Q2 net loss of $1.02 per share, versus a year-ago loss of $0.47 per share. Its net revenue dropped to $2.2 million from $4.3 million.</li>
<li>Sypris Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sypr#NASDAQ">SYPR</a>) fell 10% to $1.04 in pre-market trading after declining 9% on Friday. Sypris Solutions reported Q2 results last week.</li>
<li>RAVE Restaurant Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rave#NASDAQ">RAVE</a>) fell 9.5% to $0.6116 in pre-market trading after gaining 9% on Friday.</li>
<li>China Recycling Energy Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/creg#NASDAQ">CREG</a>) fell 8.2% to $2.92 in pre-market trading. China Recycling shares jumped 11% on Friday after reporting Q2 results.</li>
<li>OncoSec Medical Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oncs#NASDAQ">ONCS</a>) fell 8% to $3.59 in pre-market trading after reporting pricing of its public offering.</li>
<li>Acer Therapeutics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acer#NASDAQ">ACER</a>) fell 7.1% to $3.58 in pre-market trading. Acer Therapeutics shares dipped 27% on Friday after reporting Q2 loss.</li>
<li>Ocean Power Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/optt#NASDAQ">OPTT</a>) fell 6% to $1.11 in pre-market trading after dipping over 20% on Friday.</li>
<li>Genius Brands International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gnus#NASDAQ">GNUS</a>) fell 5.5% to $1.51 in pre-market trading. Genius Brands, last week, reported the purchase of 230 new episodes of programming, including Yu-Gi-Oh! ARC-V.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hht#NASDAQ">HHT</a>) fell 5.5% to $0.85 in pre-market trading. The company appointed Hung-Jen Kuo to its Board of Directors on Friday.</li>
<li>ToughBuilt Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tblt#NASDAQ">TBLT</a>) shares fell 5.1% to $0.7230 in pre-market trading. ToughBuilt Industries shares jumped over 10% on Friday after reporting Q2 results.</li>
</ul>

Penny Stocks

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACER

AIHS

APDN

CLRB

CLUB

CREG

CVAC

DTSS

FAMI

FTFT

GNUS

GOLD

GTHX

IDXG

JAGX

KTOV

LMPX

MDLY

NMTR

ONCS

OPTT

PHCF

PRNB

PSTI

RAVE

SMRT

SNDL

SNOA

SYPR

TBLT

TCDA

THMO

TIGR

TRMD

VTGN

WTRH

46 Stocks Moving in Monday's Pre-Market Session

<a href="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20200811-1200759/1200759_fbk6-bldr400.pdf?force_download=true" title="https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20200811-1200759/1200759_fbk6-bldr400.pdf?force_download=true">https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20200811-1200759/1200759_fbk6-bldr400.pdf?force_download=true</a>

BLDR

Financial Security Assurance Holdings Ltd

S&P Dow Jones Indices Announces 'Builders FirstSource Set to Join S&P MidCap 400; FB Financial & CoreCivic to Join S&P SmallCap 600'

ACLS

ACOR

AEYE

ALIM

ALRN

ARPO

ASTE

Alterity Therapeutics Limited - American Depositary Shares

ATHE

BCOR

BFRA

BOOT

BWEN

BYND

CDLX

CHFS

CNST

COHN

COKE

CORT

DBVT

DFIN

DNJR

DOYU

DRIO

ENLC

EVER

EXTR

FLGT

FOSL

FVRR

GLUU

HUYA

HZNP

IMXI

ITOS

KRMD

KTCC

LPSN

LVGO

MARA

MCHP

MDIA

MIDD

MNST

MTCH

MYOS

NEON

NEWR

NKLA

NPTN

NVAX

NXTD

PRTS

QRHC

RIOT

SGRY

SINT

SONN

SPNE

STKL

TDOC

TISI

TRHC

TRUP

UPWK

USEG

VAPO

WKEY

WLFC

ZCMD

90 Biggest Movers From Yesterday

<h3>Gainers</h3>
<ul>
<li>Biofrontera AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfra#NASDAQ">BFRA</a>) climbed 151.8% to $14.10.</li>
<li>MYOS RENS Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/myos#NASDAQ">MYOS</a>) shares climbed 73.4% to $2.15 after the company reported a narrower loss for the second quarter.</li>
<li>Key Tronic Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktcc#NASDAQ">KTCC</a>) shares gained 42% to $10.22 after the company reported Q4 results and issued FY21 guidance.</li>
<li>Marathon Patent Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) shares climbed 30.3% to $4.3150 after dropping 14% on Tuesday. Marathon Patent, last week, reported the purchase of 700 M31S+ ASIC minders and shipment of 660 S-19 Pro Bitmain Miners.</li>
<li>Aileron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alrn#NASDAQ">ALRN</a>) rose 28.6% to $1.4150. On Monday, Aileron Therapeutics reported the completion of enrollment in dose optimization expansion cohort of proof-of-concept Phase 1b study of ALRN-6924.</li>
<li>EnLink Midstream, LLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/enlc#NYSE">ENLC</a>) gained 28.5% to $3.25 after reporting results for the second quarter.</li>
<li>Fulgent Genetics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgt#NASDAQ">FLGT</a>) rose 25.8% to $37.36 after reporting an increase in Q2 EPS.</li>
<li>SeaSpine Holdings Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spne#NASDAQ">SPNE</a>) gained 24% to $13.20 after the company posted better-than-expected quarterly results.</li>
<li>LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) rose 22% to $56.38 after the company after the company reported better-than-expected Q2 sales and raised its FY20 guidance. KeyBanc and Needham also raised their price targets on the stock.</li>
<li>Astec Industries, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aste#NASDAQ">ASTE</a>) gained 20.5% to $55.00 following second-quarter results.</li>
<li>DarioHealth Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drio#NASDAQ">DRIO</a>) shares rose 20.3% to $16.65. DarioHealth reported a $28.6 million private placement, last week.</li>
<li>Team, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tisi#NYSE">TISI</a>) gained 18.9% to $4.6950 following narrower-than-expected Q2 loss.</li>
<li>Alimera Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alim#NASDAQ">ALIM</a>) gained 18.3% to $6.46. Alimera Sciences released Q2 earnings last week.</li>
<li>Modine Manufacturing Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mod#NYSE">MOD</a>) rose 17.7% to $6.72 after the company reported a narrower-than-expected quarterly loss.</li>
<li>Trupanion, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trup#NASDAQ">TRUP</a>) shares gained 17.6% to $62.11 following upbeat Q2 results.</li>
<li>International Money Express, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imxi#NASDAQ">IMXI</a>) surged 17.2% to $16.65 after the company reported better-than-expected Q2 results. JMP Securities also upgraded the company&#39;s stock from Market Perform to Outperform.</li>
<li>Donnelley Financial Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dfin#NASDAQ">DFIN</a>) gained 17.1% to $11.53 following upbeat Q2 results.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) climbed 17% to $4.1278.</li>
<li>Nxt-ID, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtd#NASDAQ">NXTD</a>) rose 16.8% to $0.6851 after declining 11% on Tuesday.</li>
<li>Oasis Petroleum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oas#NASDAQ">OAS</a>) rose 16.4% to $0.7932 after reporting quarterly earnings.</li>
<li>Aerpio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) climbed 16.3% to $1.5350 after the company announced a second clinical trial with funding from the MTEC to evaluate Razuprotafib for the prevention and treatment of ARDS in patients with moderate to severe coronavirus.</li>
<li>Horizon Therapeutics Public Limited Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hznp#NASDAQ">HZNP</a>) gained 16.2% to $71.80 after the company reported upbeat Q2 results and raised its FY20 sales guidance.</li>
<li>Boot Barn Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) jumped 15.3% to $ 23.43 after the company reported better-than-expected Q1 results.</li>
<li>Valaris plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/val#NYSE">VAL</a>) shares gained 15% to $0.4535 after gaining around 4% on Tuesday.</li>
<li>Fiverr International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fvrr#NASDAQ">FVRR</a>) rose 14.5% to $119.34 after reporting Q2 results.</li>
<li>Whiting Petroleum Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wll#NYSE">WLL</a>) gained 14% to $1.23 after surging more than 40% on Tuesday.</li>
<li>Infrastructure &amp; Energy Alternatives Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/iea#NYSE">IEA</a>) gained 13.8% to $4.05 after the company won a $77 million solar contract in Texas.</li>
<li>Boot Barn Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) rose 13.7% to $23.14 after the company reported upbeat Q1 results.</li>
<li>Coca-Cola Consolidated, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coke#NASDAQ">COKE</a>) gained 13.3% to $258.45 following upbeat quarterly earnings.</li>
<li>Extreme Networks, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/extr#NASDAQ">EXTR</a>) surged 13% to $5.36 after the company reported upbeat Q4 results. The company also issued Q1 guidance above analyst estimates.</li>
<li>Assurant, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aiz#NYSE">AIZ</a>) gained 13% to $121.17 after the company reported better-than-expected Q2 earnings.</li>
<li>Match Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtch#NASDAQ">MTCH</a>) rose 12.7% to $121.18 following strong Q2 results.</li>
<li>Reinsurance Group of America, Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rga#NYSE">RGA</a>) gained 12% to $94.91 after reporting Q2 earnings.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) rose 11.4% to $175.08 after the company announced phase 1 data from its phase 1/2 trial was well-tolerated and had a reassuring safety profile. JP Morgan also upgraded the company&#39;s from Neutral to Overweight and raised its price target from $105 to $275.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) gained 11.4% to $0.7129 after the company reported better-than-expected Q2 results.</li>
<li>Square, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sq#NYSE">SQ</a>) rose 11.3% to $152.24 after the company reported better-than-expected Q2 results.</li>
<li>Neonode, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neon#NASDAQ">NEON</a>) gained 10.2% to $9.50 after the company announced a $13.9 million private placement.</li>
<li>Walt Disney Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) rose 10.1% to $129.15 after the company reported Q2 earnings results. The company reported 57.5 million Disney+ paid subscribers as of June 27th.</li>
<li>VBI Vaccines Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vbiv#NASDAQ">VBIV</a>) jumped 10.1% to $4.82 after the company&#39;s subsidiary Variation Biotech won C$56 million for the contribution from the government of Canada to support the development of the company&#39;s coronavirus program through its phase 2 studies.</li>
<li>U.S. Energy Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/useg#NASDAQ">USEG</a>) rose 8.8% to $5.83.</li>
<li>DIRTT Environmental Solutions Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drtt#NASDAQ">DRTT</a>) shares rose 7.8% to $1.80. DIRTT released Q2 results last week.</li>
<li>HUYA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) rose 6.8% to $26.81 following reports that Tencent Holdings is in talks to merge Huya and DouYu International.</li>
<li>DBV Technologies S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbvt#NASDAQ">DBVT</a>) rose 6.6% to $2.4950. HC Wainwright &amp; Co. lowered the price target on the stock from $25 to $14. DBV Technologies shares tumbled around 43% on Tuesday after the company said the FDA has issued a Complete Response Letter regarding its BLA for investigational Viaskin Peanut, a non-invasive, once-daily epicutaneous patch to treat peanut allergies in children ages 4-11.</li>
<li>MicroVision, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvis#NASDAQ">MVIS</a>) rose 6.1% to $2.6950 ahead of quarterly earnings.</li>
<li>Quest Resource Holding Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrhc#NASDAQ">QRHC</a>) gained 6% to $1.43 after the company priced its 2.95 million share common stock offering at $1.15 per share.</li>
<li>Monster Beverage Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnst#NASDAQ">MNST</a>) rose 6% to $82.65 after the company reported better-than-expected Q2 results.</li>
<li>Clearwater Paper Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clw#NYSE">CLW</a>) shares rose 5.7% to $40.43 after the company reported upbeat Q2 results.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) rose 5.7% to $4.6810 after climbing about 7% on Tuesday.</li>
<li>DouYu International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/doyu#NASDAQ">DOYU</a>) rose 5.4% to $15.58 following reports that Tencent Holdings is in talks to merge Huya and DouYu International.</li>
<li>Rigel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rigl#NASDAQ">RIGL</a>) rose 3.8% to $2.55 following better-than-expected Q2 results.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Vapotherm, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vapo#NYSE">VAPO</a>) shares dropped 36.1% to $33.72 after the company reported Q2 results and issued Q3 outlook.</li>
<li>New Relic, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newr#NYSE">NEWR</a>) declined 25.4% to $54.85 after the company issued weak Q2 EPS guidance. JP Morgan also downgraded the company&#39;s stock from Overweight to Neutral and lowered its price target from $72 to $61.</li>
<li>EverQuote Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) fell 21.4% to $42.53 after the company reported worse-than-expected Q2 results.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 21.2% to $2.57 after the company priced its 3.415 million share offering at $2.40 per share. On Tuesday, O2TODAY reported an agreement to develop antimicrobial face masks with Sintx Technologies to help prevent spread of COVID-19 and other viral diseases.</li>
<li>Blucora, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcor#NASDAQ">BCOR</a>) dropped 19.1% to $9.67 after the company reported weak Q2 results and issued downbeat FY20 earnings forecast.</li>
<li>Lumber Liquidators Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ll#NYSE">LL</a>) fell 19% to $18.51. Lumber Liquidators swung to a profit in the second quarter.</li>
<li>Axcelis Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acls#NASDAQ">ACLS</a>) fell 18.6% to $24.78 following Q2 results.</li>
<li>Alterity Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athe#NASDAQ">ATHE</a>) fell 17.3% to $2.8350. Alterity Therapeutics shares climbed 154% on Tuesday after the company said topline results of an exploratory Phase 1b trial did not provide conclusive evidence of an analgesic benefit of KarXT on experimentally induced pain in healthy volunteers.</li>
<li>Energizer Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/enr#NYSE">ENR</a>) shares dropped 16.5% to $44.24 following downbeat quarterly earnings.</li>
<li>Zhongchao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcmd#NASDAQ">ZCMD</a>) fell 16.1% to $2.39. Zhongchao gained 21% on Tuesday after the company disclosed the renewal of its contract with J&amp;J.</li>
<li>Cardlytics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) fell 15.9% to $61.15 after the company reported weaker-than-expected Q2 sales.</li>
<li>SunOpta Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stkl#NASDAQ">STKL</a>) shares dropped 14.5% to $6.12. SunOpta posted a loss for the second quarter.</li>
<li>Owens &amp; Minor, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/omi#NYSE">OMI</a>) fell 14.4% to $14.22 after the company reported worse-than-expected Q2 sales.</li>
<li>Broadwind, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwen#NASDAQ">BWEN</a>) fell 14.3% to $4.00 after reporting Q2 results.</li>
<li>Tabula Rasa HealthCare, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trhc#NASDAQ">TRHC</a>) shares dropped 13.7% to $45.18 after the company reported downbeat Q2 sales and issued weak sales outlook.</li>
<li>Repro Med Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/krmd#NASDAQ">KRMD</a>) shares declined 13.3% to $9.48 following Q2 earnings.</li>
<li>NeoPhotonics Corp(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nptn#NYSE">NPTN</a>) fell 13% to $8.65 after the company reported Q2 earnings.</li>
<li>Teladoc Health, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tdoc#NASDAQ">TDOC</a>) dropped 12.7% to $ 217.76 after the company announced a merger agreement with Livongo.</li>
<li>Glu Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gluu#NASDAQ">GLUU</a>) fell 12.5% to $8.56 after the company reported worse-than-expected Q2 results.</li>
<li>Constellation Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnst#NASDAQ">CNST</a>) dropped 11.7% to $24.61 after the company reported downbeat Q2 earnings.</li>
<li>U.S. Auto Parts Network, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prts#NASDAQ">PRTS</a>) fell 11.5% to $ 12.18 after the company filed for mixed shelf of up to $200 million.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) fell 11.1% to $34.54 after the company reported a Q2 loss of $0.16 per share. ValueAct dissolved its stake in Nikola as of July 31.</li>
<li>Veritiv Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vrtv#NYSE">VRTV</a>) dropped 10.8% to $14.65 after the company posted a Q2 loss.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) shares fell 10.2% to $0.8663. CHF Solutions reported better-than-expected Q2 sales on Tuesday.</li>
<li>Corcept Therapeutics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cort#NASDAQ">CORT</a>) fell 10.2% to $14.08 following worse-than-expected Q2 sales..</li>
<li>Upwork Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upwk#NASDAQ">UPWK</a>) fell 10% to $15.77 after the company reported Q2 results and issued Q3 sales guidance. Upwork appointed Jeff McCombs as CFO.</li>
<li>Microchip Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mchp#NASDAQ">MCHP</a>) fell 8.1% to $98.61 after reporting Q1 results.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonn#NASDAQ">SONN</a>) fell 7.6% to $3.3450. On Tuesday, Sonnet BioTherapeutics announced at-the-market warrant repricing and exchange, resulting in expected gross proceeds to the company of up to $10.5 million.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) fell 7.5% to $24.52 after the company reported worse-than-expected Q2 results.</li>
<li>AgeX Therapeutics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/age#NYSE">AGE</a>) fell 7.3% to $1.4098 after surging 38% on Tuesday.</li>
<li>Ethan Allen Interiors Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eth#NYSE">ETH</a>) fell 7.2% to $12.89 after the company reported worse-than-expected Q4 sales.</li>
<li>Callon Petroleum Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cpe#NYSE">CPE</a>) fell 6.2% to $1.2001 after the company reported Q2 earnings results.</li>
<li>EZCORP Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>) fell 4.3% to $5.64 after the company after the company reported a Q3 loss of $0.01 per share.</li>
<li>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) fell 4.3% to $136.24. Beyond Meat posted a Q2 loss of $0.02 per share.</li>
<li>Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) shares fell 3.5% to $31.97 after the company reported a wider-than-expected Q2 loss. SVB Leerink lowered the price target for the stock from $40 to $34.</li>
</ul>

Intraday Update

DRTT

EZPW

MVIS

NVTA

RIGL

VBIV

VRTV

85 Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Valaris plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/val#NYSE">VAL</a>) shares rose 64.9% to $0.6502 in pre-market trading after gaining around 4% on Tuesday.</li>
<li>Aerpio Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arpo#NASDAQ">ARPO</a>) rose 51.5% to $2.00 in pre-market trading after the company announced a second clinical trial with funding from the MTEC to evaluate Razuprotafib for the prevention and treatment of ARDS in patients with moderate to severe coronavirus.</li>
<li>Marathon Patent Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) shares rose 29.3% to $4.28 in pre-market trading after dropping 14% on Tuesday. Marathon Patent, last week, reported the purchase of 700 M31S+ ASIC minders and shipment of 660 S-19 Pro Bitmain Miners.</li>
<li>Whiting Petroleum Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wll#NYSE">WLL</a>) rose 26.9% to $1.37 in pre-market trading after surging more than 40% on Tuesday.</li>
<li>Biofrontera AG (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bfra#NASDAQ">BFRA</a>) rose 24.8% to $6.99 in pre-market trading.</li>
<li>Acorda Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) rose 21.9% to $0.78 in pre-market trading after the company reported better-than-expected Q2 results.</li>
<li>U.S. Energy Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/useg#NASDAQ">USEG</a>) rose 21.8% to $6.53 in pre-market trading.</li>
<li>MicroVision, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mvis#NASDAQ">MVIS</a>) rose 20.1% to $3.05 in pre-market trading ahead of quarterly earnings.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) rose 18.2% to $4.02 in pre-market trading.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) rose 17.1% to $184.00 in pre-market trading r after the company announced phase 1 data from its phase 1/2 trial was well-tolerated and had a reassuring safety profile. JP Morgan also upgraded the company&#39;s from Neutral to Overweight and raised its price target from $105 to $275.</li>
<li>DouYu International Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/doyu#NASDAQ">DOYU</a>) rose 16.6% to $17.26 in pre-market trading following reports that Tencent Holdings is in talks to merge Huya and DouYu International.</li>
<li>Fulgent Genetics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/flgt#NASDAQ">FLGT</a>) rose 16.2% to $34.50 in pre-market trading after reporting an increase in Q2 EPS.</li>
<li>Nxt-ID, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nxtd#NASDAQ">NXTD</a>) rose 16.1% to $0.6806 in pre-market trading after declining 11% on Tuesday.</li>
<li>LivePerson, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpsn#NASDAQ">LPSN</a>) rose 14.2% to $52.80 in pre-market trading after the company after the company reported better-than-expected Q2 sales and raised its FY20 guidance. KeyBanc and Needham also raised their price targets on the stock.</li>
<li>HUYA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) rose 14% to $28.62 in pre-market trading following reports that Tencent Holdings is in talks to merge Huya and DouYu International.</li>
<li>Key Tronic Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ktcc#NASDAQ">KTCC</a>) shares rose 14% to $8.21 in pre-market trading after the company reported Q4 results and issued FY21 guidance.</li>
<li>Oasis Petroleum Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oas#NASDAQ">OAS</a>) rose 13.9% to $0.7760 in pre-market trading ahead of quarterly earnings.</li>
<li>AgeX Therapeutics, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/age#NYSE">AGE</a>) rose 13.8% to $1.73 in pre-market trading after surging 38% on Tuesday.</li>
<li>Acorda Therapeutics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acor#NASDAQ">ACOR</a>) rose 13.8% to $0.73 in pre-market trading following better-than-expected Q2 EPS and sales results.</li>
<li>Rigel Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rigl#NASDAQ">RIGL</a>) rose 13.8% to $2.80 in pre-market trading following better-than-expected Q2 results.</li>
<li>Aileron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alrn#NASDAQ">ALRN</a>) rose 13.6% to $1.25 in pre-market trading. On Monday, Aileron Therapeutics reported the completion of enrollment in dose optimization expansion cohort of proof-of-concept Phase 1b study of ALRN-6924.</li>
<li>Fiverr International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fvrr#NASDAQ">FVRR</a>) rose 13.2% to $118.00 in pre-market trading after reporting Q2 results.</li>
<li>DIRTT Environmental Solutions Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drtt#NASDAQ">DRTT</a>) shares rose 12.6% to $1.88 in pre-market trading. DIRTT released Q2 results last week.</li>
<li>GameStop Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gme#NYSE">GME</a>) rose 12.5% to $4.99 in pre-market trading after climbing about 7% on Tuesday.</li>
<li>Square, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sq#NYSE">SQ</a>) rose 10.8% to $151.55 in pre-market trading after the company reported better-than-expected Q2 results.</li>
<li>Boot Barn Holdings Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) rose 10.7% to $22.50 in pre-market trading after the company reported upbeat Q1 results.</li>
<li>DBV Technologies S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dbvt#NASDAQ">DBVT</a>) rose 10.3% to $2.58 in pre-market trading. HC Wainwright &amp; Co. lowered the price target on the stock from $25 to $14. DBV Technologies shares tumbled around 43% on Tuesday after the company said the FDA has issued a Complete Response Letter regarding its BLA for investigational Viaskin Peanut, a non-invasive, once-daily epicutaneous patch to treat peanut allergies in children ages 4-11.</li>
<li>Walt Disney Co (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dis#NYSE">DIS</a>) rose 6.7% to $125.10 in pre-market trading after the company reported Q2 earnings results. The company reported 57.5 million Disney+ paid subscribers as of June 27th.</li>
<li>Clearwater Paper Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/clw#NYSE">CLW</a>) shares rose 6% to $40.55 in pre-market trading after the company reported upbeat Q2 results.</li>
<li>Monster Beverage Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnst#NASDAQ">MNST</a>) rose 4.5% to $81.50 in pre-market trading after the company reported better-than-expected Q2 results.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Vapotherm, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/vapo#NYSE">VAPO</a>) fell 28% to $38.00 in pre-market trading after the company reported Q2 results and issued Q3 outlook.</li>
<li>New Relic, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/newr#NYSE">NEWR</a>) fell 19.1% to $59.50 in pre-market trading after the company issued weak Q2 EPS guidance. JP Morgan also downgraded the company&#39;s stock from Overweight to Neutral and lowered its price target from $72 to $61.</li>
<li>Nikola Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nkla#NASDAQ">NKLA</a>) fell 15.3% to $32.82 in pre-market trading after the company reported a Q2 loss of $0.16 per share. ValueAct dissolved its stake in Nikola as of July 31.</li>
<li>Alterity Therapeutics Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/athe#NASDAQ">ATHE</a>) fell 14.6% to $2.93 in pre-market trading. Alterity Therapeutics shares climbed 154% on Tuesday after the company said topline results of an exploratory Phase 1b trial did not provide conclusive evidence of an analgesic benefit of KarXT on experimentally induced pain in healthy volunteers.</li>
<li>Sintx Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sint#NASDAQ">SINT</a>) fell 13% to $2.86 in pre-market trading. On Tuesday, O2TODAY reported an agreement to develop antimicrobial face masks with Sintx Technologies to help prevent spread of COVID-19 and other viral diseases.</li>
<li>Cardlytics Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cdlx#NASDAQ">CDLX</a>) fell 12.6% to $63.50 in pre-market trading after the company reported weaker-than-expected Q2 sales.</li>
<li>Ossen Innovation Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/osn#NASDAQ">OSN</a>) fell 9.7% to $3.82 in pre-market trading after climbing around 30% on Tuesday.</li>
<li>Glu Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gluu#NASDAQ">GLUU</a>) fell 9.5% to $8.85 in pre-market trading after the company reported worse-than-expected Q2 results.</li>
<li>Invitae Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nvta#NYSE">NVTA</a>) shares fell 9.4% to $30.00 in pre-market trading after the company reported a wider-than-expected Q2 loss. SVB Leerink lowered the price target for the stock from $40 to $34.</li>
<li>EZCORP Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ezpw#NASDAQ">EZPW</a>) fell 9.2% to $5.35 in pre-market trading after the company after the company reported a Q3 loss of $0.01 per share.</li>
<li>Corcept Therapeutics Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cort#NASDAQ">CORT</a>) fell 9.2% to $14.23 in pre-market trading following worse-than-expected Q2 sales..</li>
<li>Upwork Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/upwk#NASDAQ">UPWK</a>) fell 8.6% to $16.00 in pre-market trading after the company reported Q2 results and issued Q3 sales guidance. Upwork appointed Jeff McCombs as CFO.</li>
<li>WW International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ww#NASDAQ">WW</a>) fell 8% to $24.40 in pre-market trading after the company reported worse-than-expected Q2 results.</li>
<li>DURECT Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drrx#NASDAQ">DRRX</a>) fell 8% to $2.13 in pre-market trading. On Monday, Durect reported Q2 EPS of $0.07.</li>
<li>NeoPhotonics Corp(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/nptn#NYSE">NPTN</a>) fell 8% to $9.15 in pre-market trading after the company reported Q2 earnings.</li>
<li>Beyond Meat, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bynd#NASDAQ">BYND</a>) fell 7.8% to $131.26 in pre-market trading. Beyond Meat posted a Q2 loss of $0.02 per share.</li>
<li>Callon Petroleum Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cpe#NYSE">CPE</a>) fell 6.8% to $1.17 in pre-market trading after the company reported Q2 earnings results.</li>
<li>Microchip Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mchp#NASDAQ">MCHP</a>) fell 6.8% to $100.00 in pre-market trading after reporting Q1 results.</li>
<li>Zhongchao Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zcmd#NASDAQ">ZCMD</a>) fell 6.7% to $2.66 in pre-market trading. Zhongchao gained 21% on Tuesday after the company disclosed the renewal of its contract with J&amp;J.</li>
<li>Ethan Allen Interiors Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/eth#NYSE">ETH</a>) fell 6.4% to $13.00 in pre-market trading after the company reported worse-than-expected Q4 sales.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonn#NASDAQ">SONN</a>) fell 6.4% to $3.39 in pre-market trading. On Tuesday, Sonnet BioTherapeutics announced at-the-market warrant repricing and exchange, resulting in expected gross proceeds to the company of up to $10.5 million.</li>
<li>EverQuote Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ever#NASDAQ">EVER</a>) fell 6% to $50.88 in pre-market trading after the company reported worse-than-expected Q2 results.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) shares fell 5.7% to $0.91 in pre-market trading. CHF Solutions reported better-than-expected Q2 sales on Tuesday.</li>
<li>Avalara Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avlr#NYSE">AVLR</a>) fell 5.5% to $130.00 in pre-market trading after the company announced a $500 million common stock offering.</li>
</ul>

AVLR

DRRX

54 Stocks Moving in Wednesday's Pre-Market Session

WIIM

SHLX

Shares of several energy companies are trading lower despite strength in oil prices. Oil has been volatile as investors weigh US coronavirus cases and stimulus/unemployment updates.

<h3>Gainers</h3>
<ul>
<li>Ambow Education Holding Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ambo#NYSE">AMBO</a>) shares jumped 65.3% to $3.6369.</li>
<li>Marathon Patent Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) shares climbed 64% to $3.33. Marathon Patent, last week, reported the purchase of 700 M31S+ ASIC minders and shipment of 660 S-19 Pro Bitmain Miners.</li>
<li>ADT Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adt#NYSE">ADT</a>) shares climbed 62% to $13.96 after the company announced entering into a long-term partnership with Alphabet Inc. to create a smart home security offerings. Google will invest $450 million in the company for 6.6% ownership.</li>
<li>Highway Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hiho#NASDAQ">HIHO</a>) shares jumped 32.3% to $3.48. Highway Holdings reported a delay in reporting fiscal 2020 results.</li>
<li>Riot Blockchain, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/riot#NASDAQ">RIOT</a>) gained 27.6% to $3.37. Riot Blockchain, last month, received 1,000 S19 Pro Antminers from Bitmain.</li>
<li>Borr Drilling Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/borr#NYSE">BORR</a>) climbed 26% to $1.1250 after the company issued its fleet status report.</li>
<li>PowerFleet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pwfl#NASDAQ">PWFL</a>) rose 24.1% to $5.56. PowerFleet is expected to release Q2 results on August 6.</li>
<li>Jernigan Capital, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/jcap#NYSE">JCAP</a>) gained 24% to $17.35 after the company announced it would be acquired by NexPoint Advisors for $17.30 per share in cash.</li>
<li>Varian Medical Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/var#NYSE">VAR</a>) shares rose 21.8% to $173.86 after the company announced on Sunday it will be acquired by Siemens Healthineers for $177.50 per share.</li>
<li>Immunic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imux#NASDAQ">IMUX</a>) climbed 21.5% to $20.89 after the company announced the results from its Phase 2 EMPhASIS trial of IMU-838 in patients with Relapsing-Remitting Multiple Sclerosis achieved all primary and key secondary endpoints.</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) gained 21.2% to $0.8263 after the company signed a strategic cooperation agreement with large auto dealer group to expand auto business and increase access to electric vehicles.</li>
<li>Trevena, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trvn#NASDAQ">TRVN</a>) rose 20.7% to $2.80.</li>
<li>XpresSpa Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xspa#NASDAQ">XSPA</a>) gained 20% to $4.63.</li>
<li>Universal Security Instruments, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/uuu#NYSE">UUU</a>) shares climbed 20% to $2.4250.</li>
<li>Forum Energy Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fet#NYSE">FET</a>) gained 17% to $0.5859. Forum Energy Technologies reported the expiration and results of its exchange offer and consent solicitation.</li>
<li>Mercurity Fintech Holding Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mfh#NASDAQ">MFH</a>) rose 16% to $4.035.</li>
<li>CymaBay Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbay#NASDAQ">CBAY</a>) climbed 15.6% to $4.11 after the company reported the results from its phase 3 study evaluating the safety and efficacy of seladelpar for the treatment of primary biliary cholangitis demonstrated to be efficacious, safe, and well-tolerated.</li>
<li>Kirkland&#39;s, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kirk#NASDAQ">KIRK</a>) rose 15% to $6.19.</li>
<li>Co-Diagnostics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/codx#NASDAQ">CODX</a>) surged 14.2% to $27.41 after the company announced it has received FDA emergency use authorization for its rapid COVID-19 test.</li>
<li>Ashford Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ainc#NYSE">AINC</a>) gained 14% to $5.65 after dropping 24% on Friday.</li>
<li>Cardiff Oncology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crdf#NASDAQ">CRDF</a>) shares climbed 14% to $5.47.</li>
<li>United Microelectronics Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/umc#NYSE">UMC</a>) shares rose 13.4% to $4.195. United Microelectronics, last week, reported better-than-expected Q2 results.</li>
<li>Pitney Bowes Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pbi#NYSE">PBI</a>) rose 13.3% to $3.785 after the company won $5 million of shipping and mailing technology contracts with a government agency.</li>
<li>Color Star Technology Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hht#NASDAQ">HHT</a>) climbed 12.6% to $1.3401 as company announced launching of official website.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) rose 12% to $0.9510. CHF Solutions, last week, expanded commercial presence in the Middle East with distribution arrangement for Israel and Palestine.</li>
<li>DiamondPeak Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dphc#NASDAQ">DPHC</a>) rose 11.4% to $11.41 after the company announced it will acquire Lordstown, an electric pickup truck company for the commercial fleet market.</li>
<li>Accuray Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aray#NASDAQ">ARAY</a>) shares surged 11% to $2.47.</li>
<li>Plug Power Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plug#NASDAQ">PLUG</a>) gained 11% to $8.56 after the company announced it will provide UK-based supermarket, Asda with hydrogen fuel solutions to power the lift truck fleet within the retail giant&#39;s extensive supply chain network.</li>
<li>Zovio Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zvo#NYSE">ZVO</a>) rose 10.2% to $4.34 after reporting upbeat quarterly results.</li>
<li>Lipocine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpcn#NASDAQ">LPCN</a>) rose 10.1% to $1.6950 after the company announced the publication of its LPCN 1144 liver fat study results in a peer-reviewed journal.</li>
<li>Exantas Capital Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xan#NYSE">XAN</a>) rose 9.9% to $2.4496 after the company announced it received $375 million of financing from MassMutual and Oaktree Capital.</li>
<li>International Game Technology PLC (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/igt#NYSE">IGT</a>) gained 8.5% to $10.69 after the company announced a multi-year agreement with FanDuel Group.</li>
<li>DURECT Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/drrx#NASDAQ">DRRX</a>) gained 7.7% to $2.11 in anticipation of the company&#39;s Q2 earnings report scheduled for after the close today.</li>
<li>McKesson Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mck#NYSE">MCK</a>) gained 4% to $155.82 after the company reported better-than-expected Q1 results. The company also raised its FY21 earnings guidance.</li>
<li>SunCoke Energy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sxc#NYSE">SXC</a>) gained 4% to $3.31 after the company reported better-than-expected Q2 sales.</li>
</ul>

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Resideo Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rezi#NASDAQ">REZI</a>) shares dipped 20.5% to $10.56. Resideo is expected to release Q2 earnings on August 4.</li>
<li>Tiziana Life Sciences PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlsa#NASDAQ">TLSA</a>) shares tumbled 19% to $5.66 after the company priced its 11 million ADS registered direct offering at $5.20 per ADS.</li>
<li>Alarm.com Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alrm#NASDAQ">ALRM</a>) shares dipped 17.8% to $57.56. Alarm.com is expected to release Q2 results on August 5.</li>
<li>Mid-Con Energy Partners, LP (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mcep#NASDAQ">MCEP</a>) fell 17.2% to $3.08 after climbing 30% on Friday.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) fell 16.1% to $0.7799 after the company announced a proposed common stock offering of 15.6 million shares at $0.80 per share.</li>
<li>Eastman Kodak Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kodk#NYSE">KODK</a>) shares dropped 15.8% to $18.40. Eastman Kodak shares, jumped over 318% last Wednesday, following comments by President Trump indicating the US has reached a &#39;historic&#39; deal with the company to produce critical pharmaceuticals.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonn#NASDAQ">SONN</a>) fell 15.8% to $3.46 after jumping over 41% on Friday.</li>
<li>MOGU Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mogu#NYSE">MOGU</a>) shares fell 15.1% to $2.59 after declining 13% on Friday.</li>
<li>Achieve Life Sciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/achv#NASDAQ">ACHV</a>) dropped 14.9% to $11.60. Achieve Life Sciences shares jumped 14% on Friday after the company announced that the US Patent and Trademark Office granted them a patent on novel analogs of cytisiniclinen for use in CNS and addiction indications.</li>
<li>Navios Maritime Containers L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmci#NASDAQ">NMCI</a>) fell 14.8% to $0.7755. Navios Maritime Containers reported a $6 million buyback on Friday.</li>
<li>Tupperware Brands Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tup#NYSE">TUP</a>) fell 14.8% to $13.15. Tupperware Brands, last week, reported better-than-expected Q2 results.</li>
<li>Leju Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/leju#NYSE">LEJU</a>) dropped 14.3% to $3.41.</li>
<li>Pacific Ethanol, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/peix#NASDAQ">PEIX</a>) fell 12.3% to $2.06. Pacific Ethanol expanded its high-quality alcohol production capacity last week.</li>
<li>Casper Sleep Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cspr#NYSE">CSPR</a>) fell 11.9% to $8.14.</li>
<li>CleanSpark, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clsk#NASDAQ">CLSK</a>) shares declined 11% to $6.45. CleanSpark, last week, reported contract for another Southern California microgrid.</li>
<li>Quotient Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qtnt#NASDAQ">QTNT</a>) dropped 9.2% to $7.12 after the company reported Q1 results and issued weak FY2021 sales forecast.</li>
<li>Valaris plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/val#NYSE">VAL</a>) fell 7.8% to $0.3616 after declining 7% on Friday.</li>
</ul>

ACHV

AINC

ALRM

AMBO

ARAY

BORR

CBAY

CLSK

CODX

CRDF

CSPR

DPHC

HIHO

IMUX

JCAP

KIRK

KODK

LEJU

LPCN

MCEP

MOGU

NMCI

PEIX

PLUG

PWFL

QTNT

REZI

TLSA

TRVN

XSPA

52 Stocks Moving In Monday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Highway Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hiho#NASDAQ">HIHO</a>) shares rose 97.7% to $5.20 in pre-market trading. Highway Holdings reported a delay in reporting fiscal 2020 results.</li>
<li>ADT Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/adt#NYSE">ADT</a>) rose 85.7% to $15.99 in pre-market trading after the company announced entering into a long-term partnership with Google to create the next generation of smart home security offerings. Google will invest $450 million in the company for 6.6% ownership.</li>
<li>Senmiao Technology Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aihs#NASDAQ">AIHS</a>) rose 46.7% to $1.00 in pre-market trading after the company signed a strategic cooperation agreement with large auto dealer group to expand auto business and increase access to electric vehicles.</li>
<li>Houston American Energy Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/husa#NYSE">HUSA</a>) rose 42.7% to $2.30 in pre-market trading. Houston American Energy reported a 1-for-12.5 reverse stock split effective today.</li>
<li>Marathon Patent Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mara#NASDAQ">MARA</a>) shares rose 41% to $2.86 in pre-market trading. Marathon Patent reported the purchase of 700 M31S+ ASIC minders and shipment of 660 S-19 Pro Bitmain Miners.</li>
<li>Immunic, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imux#NASDAQ">IMUX</a>) rose 36.7% to $23.50 in pre-market trading after the company announced the results from its Phase 2 EMPhASIS trial of IMU-838 in patients with Relapsing-Remitting Multiple Sclerosis achieved all primary and key secondary endpoints.</li>
<li>CymaBay Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cbay#NASDAQ">CBAY</a>) rose 36.6% to $4.85 in pre-market trading after the company reported the results from its phase 3 study evaluating the safety and efficacy of seladelpar for the treatment of primary biliary cholangitis demonstrated to be efficacious, safe, and well-tolerated.</li>
<li>Borr Drilling Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/borr#NYSE">BORR</a>) rose 25.1% to $1.12 in pre-market trading after the company issued its fleet status report.</li>
<li>Forum Energy Technologies, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fet#NYSE">FET</a>) rose 24.4% to $0.6250 in pre-market trading. Forum Energy Technologies reported the expiration and results of its exchange offer and consent solicitation.</li>
<li>Zovio Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zvo#NYSE">ZVO</a>) rose 22.8% to $4.84 in pre-market trading after reporting upbeat quarterly results.</li>
<li>Varian Medical Systems, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/var#NYSE">VAR</a>) shares rose 22.3% to $174.50 in pre-market trading after the company announced on Sunday it will be acquired by Siemens Healthineers for $177.50 per share.</li>
<li>DiamondPeak Holdings Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dphc#NASDAQ">DPHC</a>) rose 18.7% to $12.15 in pre-market trading after the company announced it will acquire Lordstown, an electric pickup truck company for the commercial fleet market.</li>
<li>DPW Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dpw#NYSE">DPW</a>) rose 16% to $3.26 in pre-market trading after the company announced its power electronics business, Coolisys Technologies will host a webinar discussing its new product line of electric vehicle chargers.</li>
<li>PowerFleet, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pwfl#NASDAQ">PWFL</a>) rose 14.1% to $5.11 in pre-market trading. PowerFleet is expected to release Q2 results on August 6.</li>
<li>Lipocine Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lpcn#NASDAQ">LPCN</a>) rose 13% to $1.74 in pre-market trading after the company announced the publication of its LPCN 1144 liver fat study results in a peer-reviewed journal.</li>
<li>Trevena, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trvn#NASDAQ">TRVN</a>) rose 10.7% to $2.57 in pre-market trading.</li>
<li>CHF Solutions, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chfs#NASDAQ">CHFS</a>) rose 10% to $0.935 in pre-market trading. CHF Solutions, last week, expanded commercial presence in the Middle East with distribution arrangement for Israel and Palestine.</li>
<li>Exantas Capital Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/xan#NYSE">XAN</a>) rose 9.4% to $2.45 in pre-market trading after the company announced it received $375 million of financing from MassMutual and Oaktree Capital.</li>
<li>Muscle Maker, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gril#NASDAQ">GRIL</a>) rose 8.5% to $2.30 in pre-market trading after declining 7% on Friday.</li>
<li>Pacific Biosciences of California, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pacb#NASDAQ">PACB</a>) rose 7.2% to $4.00 in pre-market trading after the company and Asuragen announced their clinical research collaboration aimed at developed molecular assays based on PacBio&#39;s Single Molecule, Real-Time Sequencing technology.</li>
</ul>

Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>
<h3>Losers</h3>
<ul>
<li>Betterware de Mexico, S.A.P.I. de C.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bwmx#NASDAQ">BWMX</a>) fell 22.1% to $10.13 in pre-market trading after reporting surging over 60% on Friday.</li>
<li>VistaGen Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtgn#NASDAQ">VTGN</a>) fell 15.1% to $0.7899 in pre-market trading after the company announced a proposed common stock offering of 15.6 million shares at $0.80 per share.</li>
<li>Valaris plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/val#NYSE">VAL</a>) fell 14.2% to $0.3710 in pre-market trading after declining 7% on Friday.</li>
<li>MOGU Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mogu#NYSE">MOGU</a>) shares fell 13.9% to $2.61 in pre-market trading after declining 13% on Friday.</li>
<li>Navios Maritime Containers L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmci#NASDAQ">NMCI</a>) fell 10.3% to $0.8151 in pre-market trading. Navios Maritime Containers reported a $6 million buyback on Friday.</li>
<li>Zion Oil &amp; Gas, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zn#NASDAQ">ZN</a>) fell 9.4% to $0.4075 in pre-market trading. Zion Oil &amp; Gas shares gained over 65% on Friday after the company disclosed that it has received drilling plan approval for next well in Israel.</li>
<li>Tiziana Life Sciences PLC (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlsa#NASDAQ">TLSA</a>) fell 8.4% to $6.40 in pre-market trading after the company priced its 11 million ADS registered direct offering at $5.20 per ADS.</li>
<li>Precipio, Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prpo#NASDAQ">PRPO</a>) fell 6.4% to $2.94 in pre-market trading. Precipio reported the commercial launch of coronavirus antibody test last week.</li>
<li>Town Sports International Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/club#NASDAQ">CLUB</a>) fell 6% to $0.4010 in pre-market trading after declining around 5% on Friday.</li>
<li>Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sonn#NASDAQ">SONN</a>) fell 5.1% to $3.90 in pre-market trading after jumping over 41% on Friday.</li>
</ul>

BWMX

GRIL

HUSA

PACB

PRPO

30 Stocks Moving in Monday's Pre-Market Session

Bonds

Financing

Valaris Continues To Have Discussions With Lenders & Bondholders Regarding Terms Of A Potential Comprehensive Restructuring Of Indebtedness

Recent Quotes

Related Companies

Valaris Frequently Asked Questions

How do I buy Valaris (VAL) stock?

Who are Valaris's (VAL) competitors?

What is the target price for Valaris (VAL) stock?

Current Stock Price for Valaris (VAL)?

Does Valaris (VAL) pay a dividend?

When is Valaris (NYSE:VAL) reporting earnings?

Is Valaris (VAL) going to split?

What sector and industry does Valaris (VAL) operate in?